Kurma Partners is a Paris-based venture capital firm specializing in healthcare and biotechnology, investing from company creation through growth stages across Europe. The firm manages over €470 million and focuses on transforming academic scientific discoveries into biotech and medtech companies.
59% of their portfolio is in Biotech & Life Sciences. Deal activity increased 150% year-over-year (10 deals in the last 12 months). Average disclosed round size is $41.2M (across 13 rounds with reported amounts).
Portfolio
46
Fund Size
$252M
Top Stage
Series A
Last 12 Mo
7
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
56 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Laigo Bio | Seed | — | Mar 2026 |
 Alveus Therapeutics | Series A | $160M | Jan 2026 |
 Hopia | Unknown | — | Jan 2026 |
| Laigo Bio | Seed | — | Dec 2025 |
 Damae Medical | Series B | — | Nov 2025 |
 Adcytherix | Series A | — | Oct 2025 |
 Step Pharma | Series C | — | Oct 2025 |
 NUCLIDIUM | Unknown | $79M | Jul 2025 |
 Elkedonia | Seed | $12.2M | Jun 2025 |
 Deepull | Series C | — | Apr 2025 |
 Poppins | Unknown | — | Apr 2025 |
 Coave Therapeutics | Series A | $33M | Jan 2025 |
| NUCLIDIUM | Series B | — | Jan 2025 |
 Spotlight Medical | Seed | — | Jul 2024 |
 Scirhom | Series A | — | Jul 2024 |
 Memo Therapeutics | Series C | — | May 2024 |
 Vico Therapeutics | Series B | $60M | Jan 2024 |
 Axithra | Unknown | — | Sep 2023 |
| Axithra | Seed | — | Jan 2023 |
 Shorla Oncology | Series B | $35M | Jan 2023 |
| CCorteria | Series A | — | Jan 2023 |
 ImCheck | Series C | — | Jun 2022 |
 DNA Script | Series C | $35M | Jan 2022 |
| Deepull | Series B | — | Jan 2022 |
| TTarged Biopharmaceuticals | Series A | — | Jan 2022 |
Page 1 of 3
Top Co-Investors
Bpifrance13 shared
Idinvest Partners12 shared
Ysios Capital9 shared
Andera Partners8 shared
EQT Life Sciences7 shared
Eurazeo7 shared
Pontifax6 shared
Pureos Bioventures6 shared
Roche Venture Fund6 shared
Columbus Venture Partners6 shared
Angelini Ventures5 shared
Hadean Ventures4 shared
Sunstone Life Science Ventures4 shared
Verve Ventures4 shared
Fund+4 shared
HealthCap4 shared
BNP Paribas4 shared
OrbiMed3 shared
RA Capital Management3 shared
UI Investissement3 shared
Last updated: 7 September 2026